Cardiomyopathies and Heart Failure - Biomolecular, Infectious and Immune Mechanisms
by Springer US
VAT included - FREE Shipping
Do you like this product? Spread the word!
$167.02 incl. VAT
Only 1 items available Only 1 items available
Check other buying options
1 Offer for $206.03
Sold by Dodax EU
$206.03 incl. VAT
Delivery: between Thursday, September 30, 2021 and Monday, October 4, 2021
DUCTORYCHAPTER CARDIOMYOPATHIESANDHEARTFAILURE Biomolecular,InfectiousandImmuneMechanisms AkiraMatsumori,MD,PhD DepartmentofCardiovascularMedicine KyotoUniversityGraduateSchoolofMedicine Kyoto,Japan 1 SUMMARY Theclinicalpresentationofviralmyocarditisisvariable. Whenmyocardial necrosis is diffuse, congestive heart failure develops, and later, dilated cardiomyopathy. If the myocardial lesions are localized, a ventricular aneurysmforms. Whencomplicatedbyarrhythmias,myocarditispresentsas arrhythmogenic right ventricular cardiomyopathy. When myocardial necrosisislocalizedtothesubendocardialregion,restrictivecardiomyopathy may develop. While it has not been established that hypertrophic cardiomyopathy maybeacomplicationofviral myocarditis, asymmetrical septal hypertrophy has, in fact, sometimesbeen observed in patients with myocarditis. TheimportanceofhepatitisCvirusinfectionhasrecentlybeen notedinpatientswithmyocarditis,dilatedandhypertrophiccardiomyopathy.
57 SW-Abb., 25 Farbabb.
Number of Pages:
0.234 x 0.154 x 0.02 m; 0.821 kg